Galera Therapeutics's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Galera Therapeutics (NASDAQ:GRTX) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with an estimated EPS of $-0.40. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, GRTX's stock price has been sensitive to earnings performance, with a 10.03% drop after missing EPS last quarter. Over the past year, GRTX shares have declined by 92.8%, indicating a bearish sentiment among long-term shareholders.
November 13, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Galera Therapeutics is anticipated to report a quarterly EPS of $-0.40. Past earnings misses have led to significant stock price drops, and with a 92.8% decline over the past year, investor sentiment is likely bearish.
Given the historical stock price sensitivity to earnings reports and the significant decline over the past year, it is likely that any negative deviation from the expected EPS or guidance could lead to a further decrease in GRTX's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100